Ticker: VKTX | Published: 2026-09-23
Obesity drug data pop
Viking is rallying violently on strong VK2735 weight loss maintenance trial data, with analysts raising price targets on the obesity drug candidate.
Sources: https://www.investing.com/news/analyst-ratings/4913205, https://finance.yahoo.com/healthcare/articles/viking-therapeutics-stock-surges-36-123819508.html, https://finance.yahoo.com/markets/stocks/articl